14 results on '"Zaoutis, T."'
Search Results
2. Healthcare-associated Infections-Can We Do Better?
- Author
-
Kopsidas I, Collins M, and Zaoutis T
- Subjects
- Child, Epidemiological Monitoring, Humans, Organizational Culture, Practice Guidelines as Topic, Cross Infection prevention & control, Evidence-Based Practice methods, Infection Control methods
- Abstract
Competing Interests: The authors have no funding or conflicts of interest to disclose.
- Published
- 2021
- Full Text
- View/download PDF
3. Association of Empiric Antibiotic Regimen Discordance With 30-Day Mortality in Neonatal and Pediatric Bloodstream Infection-A Global Retrospective Cohort Study.
- Author
-
Cook A, Hsia Y, Russell N, Sharland M, Cheung K, Grimwood K, Cross J, Cotrim da Cunha D, Magalhães GR, Renk H, Hindocha A, McMaster P, Okomo U, Darboe S, Alvarez-Uria G, Jinka DR, Murki S, Kandraju H, Dharmapalan D, Esposito S, Bianchini S, Fukuoka K, Aizawa Y, Jimenez-Juarez RN, Ojeda-Diezbarroso K, Pirš M, Rožič M, Anugulruengkitt S, Jantarabenjakul W, Cheng CL, Jian BX, Spyridakis E, Zaoutis T, and Bielicki J
- Subjects
- Adolescent, Anti-Bacterial Agents administration & dosage, Bacteremia microbiology, Bacterial Infections drug therapy, Bacterial Infections mortality, Child, Child, Preschool, Cohort Studies, Cross Infection drug therapy, Cross Infection microbiology, Female, Humans, Infant, Infant, Newborn, Male, Retrospective Studies, Anti-Bacterial Agents therapeutic use, Bacteremia drug therapy, Bacteremia mortality, Global Health, Sepsis drug therapy, Sepsis mortality
- Abstract
Background: While there have been studies in adults reporting discordant empiric antibiotic treatment associated with poor outcomes, this area is relatively unexplored in children and neonates despite evidence of increasing resistance to recommended first-line treatment regimens., Methods: Patient characteristics, antibiotic treatment, microbiology, and 30-day all-cause outcome from children <18 years with blood-culture-confirmed bacterial bloodstream infections (BSI) were collected anonymously using REDCap™ through the Global Antibiotic Prescribing and Resistance in Neonates and Children network from February 2016 to February 2017. Concordance of early empiric antibiotic treatment was determined using European Committee on Antimicrobial Susceptibility Testing interpretive guidelines. The relationship between concordance of empiric regimen and 30-day mortality was investigated using multivariable regression., Results: Four hundred fifty-two children with blood-culture-positive BSI receiving early empiric antibiotics were reported by 25 hospitals in 19 countries. Sixty percent (273/452) were under the age of 2 years. S. aureus, E. coli, and Klebsiella spp. were the most common isolates, and there were 158 unique empiric regimens prescribed. Fifteen percent (69/452) of patients received a discordant regimen, and 7.7% (35/452) died. Six percent (23/383) of patients with concordant regimen died compared with 17.4% (12/69) of patients with discordant regimen. Adjusting for age, sex, presence of comorbidity, unit type, hospital-acquired infections, and Gram stain, the odds of 30-day mortality were 2.9 (95% confidence interval: 1.2-7.0; P = 0.015) for patients receiving discordant early empiric antibiotics., Conclusions: Odds of mortality in confirmed pediatric BSI are nearly 3-fold higher for patients receiving a discordant early empiric antibiotic regimen. The impact of improved concordance of early empiric treatment on mortality, particularly in critically ill patients, needs further evaluation., Competing Interests: The authors have no conflicts of interest to disclose., (Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
4. A Survey on National Pediatric Antibiotic Stewardship Programs, Networks and Guidelines in 23 European Countries.
- Author
-
Kopsidas I, Vergnano S, Spyridis N, Zaoutis T, and Patel S
- Subjects
- Child, Drug Resistance, Bacterial, Europe, Humans, Practice Guidelines as Topic, Surveys and Questionnaires, Anti-Bacterial Agents therapeutic use, Antimicrobial Stewardship standards, Drug Utilization standards
- Abstract
Background: Misuse, overuse of antimicrobials and increasing rates of antimicrobial resistance are well-recognized problems throughout Europe. The aim of this survey was to describe the current pediatric antibiotic stewardship (PAS) landscape across Europe and identify gaps, in terms of national programs, networks and guidelines., Methods: A survey of 17 questions was circulated in July 2019 among 24 European pediatric infectious disease researchers and clinicians, professors and heads of department on the existence of PAS programs, national networks and meetings, established competencies, metrics and guidelines., Results: We received responses from 23 countries. National guidelines on the management of children with common infections treated in hospital settings exist in 15 of 23 (70%); only 8 of 15 (53%) had been updated within the previous 4 years. Most provide guidance on antibiotic initiation and duration (14 of 15, 93%), but few on when to transition from intravenous to oral antibiotics (7 of 15, 47%). National PAS competencies have only been developed in 4 countries; only 1 addressed both community and hospital prescribing. Organized national PAS networks are only established in the United Kingdom and Germany; 21 of 23, 91% countries had no agreed metric for antibiotic prescribing in children; 2 of 23 were based on daily defined doses., Conclusions: Fragmented implementation of PAS programs, no agreed metrics, lack of established PAS competencies and national PAS networks along with inexistent funding is alarming in view of existing high rates of antimicrobial resistance in Europe.
- Published
- 2020
- Full Text
- View/download PDF
5. Variation in Outpatient Antibiotic Dispensing for Respiratory Infections in Children by Clinician Specialty and Treatment Setting.
- Author
-
Agiro A, Gautam S, Wall E, Hackell J, Helm M, Barron J, Zaoutis T, Fleming-Dutra KE, Hicks LA, and Rosenberg A
- Subjects
- Adolescent, Child, Child, Preschool, Cross-Sectional Studies, Female, Humans, Male, Outpatients statistics & numerical data, Retrospective Studies, Anti-Bacterial Agents administration & dosage, Drug Utilization statistics & numerical data, Practice Patterns, Physicians' statistics & numerical data, Respiratory Tract Infections drug therapy
- Abstract
Background: Antibiotics are commonly prescribed for children with acute respiratory infections (ARIs). This study describes the distribution of ARI diagnoses and specifically quantifies antibiotic dispensing for bronchitis and upper respiratory infection (URI) by treatment setting and specialty., Methods: This retrospective, observational cross-sectional study used data from the HealthCore Integrated Research Environment containing claims from 14 commercial health plans for 2012 to 2014. Children (2-17 years) with first-episode ARI were identified by diagnosis of acute otitis media (AOM), sinusitis, pharyngitis, bronchitis or URI with no competing infections or chronic illnesses. Treatment setting was where diagnoses were made: primary care offices, urgent care centers (UCC), retail health clinics (RHCs) or emergency departments. Primary outcome measure was antibiotic prescription fills from pharmacies within 2 days of start of ARI episode., Results: For URI, the highest proportions in antibiotic dispensing were ordered by office-based or UCC family physicians (28% and 30%, respectively) and office-based or UCC nurse practitioners/physician assistants (30% and 29%, respectively). Across all settings and specialties, there was high proportion of antibiotic dispensing for bronchitis (75%). Overall, 48% of 544,531 children diagnosed with ARI filled antibiotics. Nurse practitioners/physician assistants in RHC made the most diagnoses of AOM (24%) and streptococcal pharyngitis (22%)., Conclusions: Outreach efforts to decrease antibiotic dispensing for URI can be focused on office-based and UCC family physicians and nurse practitioners/physician assistants. All specialties need widespread interventions to reduce antibiotic dispensing for bronchitis. RHC nurse practitioners/physician assistants can be targeted to reduce high proportion of AOM and streptococcal pharyngitis diagnoses.
- Published
- 2018
- Full Text
- View/download PDF
6. The Impact of Clinical Pathways on Antibiotic Prescribing for Acute Otitis Media and Pharyngitis in the Emergency Department.
- Author
-
Dona D, Baraldi M, Brigadoi G, Lundin R, Perilongo G, Hamdy RF, Zaoutis T, Da Dalt L, and Giaquinto C
- Subjects
- Acute Disease, Adolescent, Anti-Bacterial Agents economics, Antimicrobial Stewardship economics, Child, Child, Preschool, Emergency Service, Hospital statistics & numerical data, Female, Humans, Infant, Italy, Male, Otitis Media microbiology, Pharyngitis microbiology, Practice Patterns, Physicians' statistics & numerical data, Streptococcus pyogenes drug effects, Anti-Bacterial Agents therapeutic use, Critical Pathways, Drug Prescriptions statistics & numerical data, Otitis Media drug therapy, Pharyngitis drug therapy, Treatment Failure
- Abstract
Background: Although Italian pediatric antimicrobial prescription rates are among the highest in Europe, little action has been taken to improve the appropriateness of antimicrobial prescriptions. The primary aim of this study was to assess changes in antibiotic prescription before and after acute otitis media (AOM) and group A streptococcus (GAS) pharyngitis Clinical Pathway (CP) implementation; secondary aims were to compare treatment failures and to assess change in the total antibiotics costs before and after CP implementation., Methods: Pre-post quasi-experimental study comparing the 6-month period before CP implementation (baseline period: October 15, 2014, through April 15, 2015) to the 6 months after intervention (postintervention: October 15, 2015, through April 15, 2016)., Results: Two hundred ninety-five pre- and 278 postintervention emergency department visits were associated with AOM. After CP implementation, there was an increase in "wait and see" approach and a decrease in overall prescription of broad-spectrum antibiotics from 53.2% to 32.4% (P < 0.001). One hundred fifty-one pre- and 166 postimplementation clinic visits were associated with GAS pharyngitis, with a decrease in broad-spectrum prescription after CP implementation (46.4% vs. 6.6%; P < 0.001). For both conditions, no difference was found in treatment failure, and total antibiotics cost was significantly reduced after CP implementation, with a decrease especially in broad-spectrum antibiotics costs., Conclusions: A reduction in broad-spectrum antibiotic prescriptions and a reduction in the total cost of antibiotics for AOM and GAS pharyngitis along with an increase in "wait and see" prescribing for AOM indicate effectiveness of CP for antimicrobial stewardship in this setting.
- Published
- 2018
- Full Text
- View/download PDF
7. Bone and Joint Infections.
- Author
-
Saavedra-Lozano J, Falup-Pecurariu O, Faust SN, Girschick H, Hartwig N, Kaplan S, Lorrot M, Mantadakis E, Peltola H, Rojo P, Zaoutis T, and LeMair A
- Subjects
- Arthritis, Infectious epidemiology, Arthritis, Infectious etiology, Disease Management, Disease Susceptibility, Humans, Osteomyelitis epidemiology, Osteomyelitis etiology, Arthritis, Infectious diagnosis, Arthritis, Infectious therapy, Osteomyelitis diagnosis, Osteomyelitis therapy
- Published
- 2017
- Full Text
- View/download PDF
8. Assessment of hand hygiene resources and practices at the 2 children's hospitals in Greece.
- Author
-
Kouni S, Kourlaba G, Mougkou K, Maroudi S, Chavela B, Nteli C, Lourida A, Spyridis N, Zaoutis T, and Coffin S
- Subjects
- Cross-Sectional Studies, Greece, Guideline Adherence, Humans, Cross Infection prevention & control, Hand Hygiene methods, Hospitals, Pediatric
- Abstract
Background: Hand hygiene (HH) is the most effective way to prevent health care-associated infections and the spread of antimicrobial-resistant pathogens. The aim of our study was to assess the existing HH resources and current HH practices at 2 hospitals in Athens, Greece., Methods: Observational HH data and an inventory of HH resources were collected from 13 wards including medical/surgical, oncology/transplant and intensive care units, during 65, 1-hour observations periods., Results: A total of 1271 HH opportunities were observed during the study period, including 944 of Health Care Workers (HCW) and 327 of visitors and parents. The nursing HH compliance was highest (49%) followed by medical compliance (24%, P < 0.001). HCW HH compliance was highest in intensive care units and the transplant unit (64-87%). The rate of appropriate HH for HCW was 22.6%. HCW most commonly used soap and water (76.1%). The HH procedure was more likely to be appropriate when soap and water were used as compared with alcohol based hand rub (64.6% and 47.5%, P = 0.006). A marginally significant association was identified between the HH compliance rate and the number of alcohol based hand rub dispensers per room (P = 0.057). In visitors and parents, the HH compliance was found to be 19%, whereas the rate of appropriate HH was 8.9%., Conclusions: Low levels of HH were observed.
- Published
- 2014
- Full Text
- View/download PDF
9. Epidemiology, risk factors and outcome of Candida parapsilosis bloodstream infection in children.
- Author
-
Dotis J, Prasad PA, Zaoutis T, and Roilides E
- Subjects
- Adolescent, Age Factors, Candidemia mortality, Candidemia pathology, Child, Child, Preschool, Cohort Studies, Cross Infection mortality, Cross Infection pathology, Female, Hospitals, Pediatric, Humans, Infant, Male, Philadelphia epidemiology, Respiration, Artificial adverse effects, Retrospective Studies, Risk Factors, Survival Analysis, Candida isolation & purification, Candidemia drug therapy, Candidemia epidemiology, Cross Infection drug therapy, Cross Infection epidemiology
- Abstract
Background: Candida parapsilosis constitutes a common Candida spp. isolated in children with candidemia. Few data exist on risk factors and outcome of candidemia caused by C. parapsilosis in pediatric patients., Methods: We conducted a retrospective analysis of demographic data, clinical features, therapeutic procedures and outcomes associated with Candida bloodstream infections (BSIs) that occurred at the Children's Hospital of Philadelphia between 1997 and 2009., Results: Among 406 Candida BSIs, Candida albicans accounted for 198 (49%), C. parapsilosis for 99 (24%) and all other species for 109 (27%) episodes. There was no consistent change in the proportion of C. parapsilosis BSIs during the study. C. parapsilosis BSI was more frequent than non-parapsilosis Candida spp. at age ≤2 years as compared with older patients (62% versus 50%, odds ratio = 1.24, 95% confidence interval: 1.03-1.51, P = 0.038). Patients with C. parapsilosis were more likely to be mechanically ventilated within 48 hours of BSI (odds ratio = 1.38, 95% confidence interval: 1.01-1.85, P = 0.047). Presence of a urinary catheter a week before infection was a protective factor for developing candidemia due to C. parapsilosis spp. (P = 0.003). No significant differences were found between the 2 groups in the presence of central intravascular catheters, comorbidities and clinical or surgical procedures, previous administration of immunosuppressive or antifungal agents and mortality., Conclusions: C. parapsilosis is the second most frequent cause of candidemia after C. albicans. Although it is more frequent at the age of ≤2 years and is more likely associated with mechanical ventilation than other Candida spp., mortality does not significantly differ between those with and without C. parapsilosis candidemia.
- Published
- 2012
- Full Text
- View/download PDF
10. Risk factors and outcomes associated with severe clostridium difficile infection in children.
- Author
-
Kim J, Shaklee JF, Smathers S, Prasad P, Asti L, Zoltanski J, Dul M, Nerandzic M, Coffin SE, Toltzis P, and Zaoutis T
- Subjects
- Case-Control Studies, Child, Child, Preschool, Clostridioides difficile classification, Clostridioides difficile genetics, Clostridium Infections mortality, Clostridium Infections pathology, Cohort Studies, Electrophoresis, Gel, Pulsed-Field, Female, Genotype, Hospitals, Pediatric, Humans, Infant, Male, Molecular Typing, Prospective Studies, Recurrence, Risk Factors, Treatment Failure, Clostridioides difficile isolation & purification, Clostridium Infections epidemiology, Clostridium Infections microbiology
- Abstract
Background: The incidence and severity of Clostridium difficile infection (CDI) is increasing among adults; however, little is known about the epidemiology of CDI among children., Methods: We conducted a nested case-control study to identify the risk factors for and a prospective cohort study to determine the outcomes associated with severe CDI at 2 children's hospitals. Severe CDI was defined as CDI and at least 1 complication or ≥2 laboratory or clinical indicators consistent with severe disease. Studied outcomes included relapse, treatment failure, and CDI-related complications. Isolates were tested to determine North American pulsed-field gel electrophoresis type 1 lineage., Results: We analyzed 82 patients with CDI, of whom 48 had severe disease. Median age in years was 5.93 (1.78-12.16) and 1.83 (0.67-8.1) in subjects with severe and nonsevere CDI, respectively (P = 0.012). All patients with malignancy and CDI had severe disease. Nine subjects (11%) had North American pulsed-field gel electrophoresis type 1 isolates. Risk factors for severe disease included age (adjusted odds ratio [95% confidence interval]: 1.12 [1.02, 1.24]) and receipt of 3 antibiotic classes in the 30 days before infection (3.95 [1.19, 13.11]). If infants less than 1 year of age were excluded, only receipt of 3 antibiotic classes remained significantly associated with severe disease. Neither the rate of relapse nor treatment failure differed significantly between patients with severe and nonsevere CDI. There was 1 death., Conclusions: Increasing age and exposure to multiple antibiotic classes were risk factors for severe CDI. Although most patients studied had severe disease, complications were infrequent. Relapse rates were similar to those reported in adults.
- Published
- 2012
- Full Text
- View/download PDF
11. Improving surveillance for pediatric Clostridium difficile infection: derivation and validation of an accurate case-finding tool.
- Author
-
Shaklee J, Zerr DM, Elward A, Newland J, Leckerman K, Asti L, Guth R, Bass J, Selvarangan R, Coffin S, and Zaoutis T
- Subjects
- Adolescent, Child, Child, Preschool, Cross-Sectional Studies, Humans, Infant, Infant, Newborn, Predictive Value of Tests, Sensitivity and Specificity, Clostridioides difficile isolation & purification, Clostridium Infections diagnosis, Cross Infection diagnosis, Epidemiologic Methods
- Abstract
Background: The incidence of Clostridium difficile infection (CDI) is increasing. Multicenter studies of CDI have been limited by the lack of valid case-finding tools. To facilitate pediatric studies of CDI, we constructed a case-finding tool using administrative data., Methods: A cross-sectional study was performed using the Pediatric Health Information System database and microbiologic data from 4 member hospitals. Using patients with laboratory-confirmed CDI as the standard, we determined the sensitivity, specificity, positive (PPV), and negative (NPV) predictive value of an ICD-9-CM code for identifying children with laboratory-confirmed CDI., Results: We identified 109 patients with laboratory-confirmed CDI and 119 patients with CDI ICD-9-CM code. The sensitivity, specificity, PPV, and NPV were 80.73%, 99.89%, 73.95%, and 99.92%, respectively, for this comparison. The addition of a billing charge for both C. difficile laboratory test and treatment medication to the ICD-9-CM code increased the specificity and PPV, but resulted in a slight decrease in the sensitivity and NPV. The use of administrative data for identifying pediatric cases of CDI was also compared with that of chart review, and was found to be a stronger surrogate for identifying cases of CDI when compared with microbiology data alone., Conclusions: These results demonstrate that the use of administrative data for CDI is a reliable and accurate method for identifying pediatric patients with CDI. The use of administrative data could facilitate the completion of larger studies due to its greater accessibility and reduced costs.
- Published
- 2011
- Full Text
- View/download PDF
12. Safety experience with caspofungin in pediatric patients.
- Author
-
Zaoutis T, Lehrnbecher T, Groll AH, Steinbach WJ, Jafri HS, Maertens J, Ngai AL, Chow JW, Taylor AF, Strohmaier KM, Bourque M, Bradshaw SK, Petrecz M, and Kartsonis NA
- Subjects
- Adolescent, Antifungal Agents therapeutic use, Caspofungin, Child, Child, Preschool, Clinical Trials as Topic, Echinocandins therapeutic use, Humans, Infant, Infant, Newborn, Lipopeptides, Prospective Studies, Antifungal Agents adverse effects, Echinocandins adverse effects, Mycoses drug therapy
- Abstract
We analyzed the caspofungin safety experience in 5 clinical registration studies in 171 pediatric patients, 1 week to 17 years of age. Caspofungin was administered for 1 to 87 (mean 12.1) days. The most common drug-related adverse events were fever, increased AST, increased ALT, and rash; few events were serious or required treatment discontinuation. Caspofungin was well tolerated in this pediatric population.
- Published
- 2009
- Full Text
- View/download PDF
13. Antibiotic use in neonatal intensive care units and adherence with Centers for Disease Control and Prevention 12 Step Campaign to Prevent Antimicrobial Resistance.
- Author
-
Patel SJ, Oshodi A, Prasad P, Delamora P, Larson E, Zaoutis T, Paul DA, and Saiman L
- Subjects
- Centers for Disease Control and Prevention, U.S., Cross Infection drug therapy, Cross Infection prevention & control, Female, Humans, Infant, Newborn, Infant, Very Low Birth Weight, Male, Retrospective Studies, United States, Anti-Bacterial Agents administration & dosage, Drug Resistance, Bacterial, Guideline Adherence, Intensive Care Units, Neonatal standards
- Abstract
Background: The Centers for Disease Control and Prevention (CDC) 12-Step Campaign to Prevent Antimicrobial Resistance was launched to educate clinicians about antimicrobial resistance and provide strategies to improve clinical practice, including antimicrobial utilization., Methods: A multicenter retrospective observational study of antibiotic use was performed in 4 tertiary care NICUs to assess adherence to the guidelines defined by the CDC 12-Step Campaign using predetermined criteria. Fifty infants per NICU were identified who received intravenous antibiotics at greater than 72 hours of age. Antibiotic regimens, clinical and microbiologic data, and indications for initiation and continuation of antibiotics (after 72 hours of use) were recorded. Inappropriate utilization was characterized at initiation, continuation, by agent, and by CDC 12-Step., Results: Two hundred neonates received 323 antibiotic courses totaling 3344 antibiotic-days. Ninety (28%) courses and 806 (24%) days were judged to be nonadherent to a CDC 12-Step. Inappropriate use was more common with continuation of antibiotics (39%) than with initiation (4%) of therapy. Vancomycin was the most commonly used drug (n = 895 antibiotic-days) of which 284 (32%) days were considered inappropriate. Carbapenems were used less frequently (n = 310 antibiotic-days), and 132 (43%) of these days were inappropriate. Common reasons for nonadherence at the time of continuation included failure to narrow antibiotic coverage after microbiologic results were known and prolonged antibiotic prophylaxis after surgery with chest tube placement., Conclusions: The CDC 12-Step Campaign can be modified for neonatal populations. Inappropriate antibiotic prescribing was common in the study NICUs. Improvement efforts should target antibiotic use 72 hours after initiation, particularly focusing on narrowing therapy and instituting protocols to limit prophylaxis.
- Published
- 2009
- Full Text
- View/download PDF
14. Caspofungin for the treatment of pediatric fungal infections.
- Author
-
Fisher BT and Zaoutis T
- Subjects
- Antifungal Agents pharmacology, Aspergillus drug effects, Candida drug effects, Caspofungin, Child, Child, Preschool, Drug Approval, Echinocandins pharmacology, Humans, Infant, Lipopeptides, United States, United States Food and Drug Administration, Antifungal Agents therapeutic use, Aspergillosis drug therapy, Candidiasis drug therapy, Echinocandins therapeutic use
- Published
- 2008
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.